CMS’s latest IPPS update signals a meaningful shift in how hospitals are reimbursed for joint replacement care. By adjusting payment rates and refining quality‑linked incentives, the rule places greater emphasis on full‑episode performance, complication reduction, and cost efficiency. These changes reshape the financial landscape for orthopedic programs and accelerate the move toward data‑driven, value‑based joint replacement care.